Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16870917 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Spironolactone Versus Amiloride as an Add on Agent in Resistant Hypertension
Condition: Hypertension
Interventions: Drug: spironolactone;   Drug: amiloride

Indicates status has not been verified in more than two years